394 results on '"Dewald G"'
Search Results
2. Ecological Aspects of Some Bluestem Communities in the Red River Valley
3. Dysgranulopoiesis is an independent adverse prognostic factor in chronic myeloid disorders with an isolated interstitial deletion of chromosome 5q
4. Solid State Fluorination on the Minute Scale: Synthesis of WO3-x Fx with Photocatalytic Activity
5. JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained
6. WHO-defined chronic neutrophilic leukemia: a long-term analysis of 12 cases and a critical review of the literature
7. Primary pulmonary MALT lymphomas show frequent and heterogeneous cytogenetic abnormalities, including aneuploidy and translocations involving API2 and MALT1 and IGH and MALT1
8. Low expression of the myeloid differentiation antigen CD65s, a feature of poorly differentiated AML in older adults: study of 711 patients enrolled in ECOG trials
9. Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphoma
10. Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma
11. Agnogenic myeloid metaplasia associated with Klinefelter syndrome: a case report
12. Idiopathic Angioedema and Coagulation Factor XII Mutation: 372
13. A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare ‘poor prognosis’ myeloid malignancies
14. Efficacy of calcium ionophore A23187 oocyte activation for generating parthenotes for human embryo research
15. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia: 1
16. Hereditary angio-oedema with normal C1 inhibitor in a family with affected women and men
17. Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia
18. Recurrent angio-oedema induced by oral contraceptives or hormonal replacement therapy
19. Diagnostic utility of fluorescence in situ hybridization in mantle-cell lymphoma
20. Isolated isochromosome 17q: a distinct type of mixed myeloproliferative disorder/myelodysplastic syndrome with an aggressive clinical course
21. OVEREXPRESSION AND UNDEREXPRESSION OF PMP-22 AS A MECHANISM UNDERLYING HUMAN HEREDITARY NEUROPATHIES.
22. Polyarenemethylidenes: A New Class of Low Gap Polymers
23. 13 Update of cytogenetic risk factors in MDS (Part II): a strategy to incorporate fluorescence in situ hybridization (FISH) and “FISH on a Chip” (aCGH) results in future clinical trials for the myelodysplastic syndromes (MDS)
24. Exclusion of the HLA Locus from a Large Portion of the Long Arm of Chromosome 6
25. Outcome of 1,229 Adult Philadelphia Chromosome Negative B Acute Lyrnphoblastic Leukemia (B ALL) Patients (pts) From the International UKALLXII/E2993 Trial No Difference In Results Between B Cell Immuno phenotypic Subgroups
26. Genetische Polymorphismen der Komplementkomponenten C2, C4 und Faktor B bei Psoriasis
27. C6-Polymorphismus der sechsten Komplementkomponente: Ein neues, aussagekräftiges System in der Abstammungsbegutachtung
28. HLA-linked complement polymorphisms (C2, BF) in psoriasis
29. The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trial
30. Pregnancies in Women with Hereditary Angioedema due to Mutations in the F12 gene
31. Hereditary Angioedema due to Missense Mutations Thr309Lys and Thr309Arg in the Factor 12 Gene
32. Long term survival in acute myelogenous leukemia: a second follow-up of the Fourth International Workshop on Chromosomes in Leukemia
33. A randomized trial of anthracycline dose intensification during induction of younger patients with acute myeloid leukemia: Results of Eastern Cooperative Oncology Group study E1900
34. Dysgranulopoiesis is an independent adverse prognostic factor in chronic myeloid disorders with an isolated interstitial deletion of chromosome 5q
35. Natural history of patients with myelodysplastic syndromes (MDS) with interstitial deletions of chromosome 5q detected on G-banded karyotyping
36. PHILADELPHIA CHROMOSOME MOSAICISM DUE TO ADDITIONAL CYTOGENETIC ABNORMALITIES IN CHRONIC MYELOID LEUKEMIA MIGHT ADVERSELY AFFECT PROGNOSIS AND RESPONSE TO IMATINIB.
37. 10 PHILADELPHIA CHROMOSOME MOSAICISM DUE TO ADDITIONAL CYTOGENETIC ABNORMALITIES IN CHRONIC MYELOID LEUKEMIA MIGHT ADVERSELY AFFECT PROGNOSIS AND RESPONSE TO IMATINIB.
38. Select high risk genetic features predict earlier progression following chemotherapy in chronic lymphocytic leukemia: Prospective randomized trial (Intergroup E2997) to evaluate justification for risk-adapted therapy
39. Hereditary angio-oedema with normal C1 inhibitor in a family with affected women and men
40. Der(6)t(1;6)(q21–23;p21.3): The most specific chromosomal translocation in myelofibrosis with myeloid metaplasia
41. The clinical spectrum of adult acute myeloid leukemia (AML) associated with core binding factor (CBF) translocations
42. Hematologic and cytogenetic (CTG) response to lenalidomide (CC-5013) in patients with transfusion-dependent (TD) myelodysplastic syndrome (MDS) and chromosome 5q31.1 deletion: Results of the multicenter MDS-003 Study
43. Gemtuzumab-ozogamicin (GO; Mylotarg®) as part of consolidation therapy for AML before autograft: Low incidence of hepatic veno-occlusive disease
44. P-121 Lenalidomide (CC-5013; revlimid™)-inducedred blood cell (RBC) transfusion-independence (TI) responses in low-/INT-1-risk patients with myelodysplastic syndromes (MDS): Results of the multicenter mds 002 study
45. WHO-defined chronic neutrophilic leukemia: a long-term analysis of 12 cases and a critical review of the literature
46. Methylation of the Tumor Suppressor Gene PTPRO (Receptor-Type Protein Tyrosine Phosphatase) Is Associated with Expression of Important Apoptosis-Related Proteins in Chronic Lymphocytic Leukemia (CLL).
47. NCCTG trial of gemcitabine for relapsed B-cell chronic lymphocytic leukemia
48. A surrogate marker profile for PML/RARα expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes
49. Primary pulmonary MALT lymphomas show frequent and heterogeneous cytogenetic abnormalities, including aneuploidy and translocations involving API2 and MALT1 and IGH and MALT1
50. Secondary Acute Myelogenous Leukemia with MLL Gene Rearrangement Following Radioimmunotherapy (RAIT) for Non-Hodgkin's Lymphoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.